Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth Publisher



Salari F1 ; Fakhraie G1 ; Amoli FA1 ; Zareighanavati M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cornea, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Current Ophthalmology Published:2022


Abstract

Purpose: To report a case of intracameral injection of methotrexate (MTX) to treat the epithelial ingrowth that occurred following glaucoma surgery. Methods: A case report of a 40-year-old male with epithelial ingrowth after implantation of Ahmed glaucoma valve. Results: The patient was treated with 11 doses of weekly intracameral MTX (400 mg/0.1 ml). Clinical evidence of recurrence was not observed after 11 months of follow-up. Discussion: Intracameral MTX can be used as an alternative for the treatment of epithelial ingrowth. © 2022 Iranian Society of Ophthalmology. All rights reserved.
Related Docs
1. Intravitreal Methotrexate, Journal of Ophthalmic and Vision Research (2021)